The third outbreak of novel coronavirus pneumonia in Hong Kong is severe. At 3 pm on August 7, Carrie Lam, the Chief Executive of the Hong Kong Special Administrative Region, held a press conference and announced a one-time free voluntary virus test for all citizens in Hong Kong. Three mainland testing agencies are responsible for the test, which is expected to start in two weeks.

Image source: Xinhua News Agency

Earlier, at the request of the Hong Kong Special Administrative Region government, under the overall planning and command of the central government, the National Health Commission quickly formed a mainland nucleic acid testing support team to go to Hong Kong on August 2.

As a third-party testing agency designated by the country and Hong Kong, the Hybribio Anti-epidemic Pioneers were assembled to protect the lives and health of Hong Kong residents, setting off again and embarking on the anti-epidemic journey.

The Hybribio Hong Kong Molecular Pathology Detection Center (HK-MPDC), as the first batch of third-party testing agencies to be recognized by the Hong Kong Special Administrative Region Government for COVID-19 nucleic acid testing, has continued to fight the epidemic and protect the lives and health of Hong Kong people with strength.

In order to undertake the testing tasks in Hong Kong, Hybribio has made full use of its own testing capabilities and professional advantages, such as service network, to respond to the sharp rebound of the Hong Kong epidemic and urgent need to improve nucleic acid testing capabilities. Hybribio quickly assembled a group of experienced specialists in the field of nucleic acid testing for novel coronavirus, allocated and purchased testing consumables and instruments, which improved HK-MPDC's single-day nucleic acid testing capabilities in a short time and digested the testing tasks entrusted by the Hong Kong Special Administrative Region Government with quality and quantity.

Among the confirmed cases of novel coronary pneumonia in Hong Kong, there are a considerable number of cases with unknown origin, which means that the uncertainty of the epidemic and the risk of transmission have increased sharply, and measures can be taken to curb the spread of the epidemic as soon as the results are available. HK-MPDC's detection team has withstood huge test volume and pressures, now it continues displaying its professional quality of "high standards, strict specifications, and fast efficiency" to serve the overall situation of the SARS anti-epidemic!

Hybribio vanguard travelled across the country to fight the epidemic

Since the outbreak of the novel coronavirus epidemic, the medical laboratories under Hybribio have actively responded to the requirements of government departments at all levels and undertook the task of detecting the nucleic acid of the novel coronavirus. On August 5th, the Guangdong Provincial Health and Health Commission held a symposium for companies to fight the epidemic in Guangzhou. As one of the representatives of companies involved in epidemic prevention and control, Hybribio attended the meeting and was presented with a commemorative plaque of "Hand in hand to fight the epidemic and overcome difficulties" , Thanks to participating companies for actively serving the overall situation of epidemic prevention and control and making important contributions in the process of fighting the epidemic, and further encouraging companies to give full play to their advantages and make greater contributions to epidemic prevention and control.

Hybribio Deputy General Manager Guan Zhisheng (second from the left) accepted the commendation on behalf of Hybribio

Image source: Guangdong Provincial Health Commission official website

As a third-party medical inspection force to fight the epidemic, Hybribio Medical Laboratories has withstood the pressure under the tight time, heavy tasks, and severe prevention and control situation, and exerted its overall coordination and rapid execution of capabilities, with a strong team of elite soldiers and high-quality inspection services. Hybribio team run on the front line of the fight against the epidemic, rapidly improves the nucleic acid testing capabilities of various regions, and ensuring the resumption of work, production, school and foreign import across the country. As of the beginning of August, more than 2.5 million novel coronavirus nucleic acid tests have been completed, making a positive contribution to winning the battle against the epidemic!

Letter of thanks from Guangdong Provincial Health Commission to Hybribio

— Beijing·War Epidemic —

In the face of the cluster of epidemics in Beijing's Xinfadi market, Hybribio leveraged its previous extensive experience in major war epidemics in Wuhan, Guangzhou and other major epidemics, and pooled the strength of the company to help Beijing carry out comprehensive nucleic acid testing. As of June 25, the laboratory of Hybribio Beijing Medical Laboratory has completed more than 200,000 tests, becoming one of the absolute main forces in Beijing to participate in the precision prevention and control of nucleic acid testing.

— Wuhan·War Epidemic —

On May 14, Wuhan city started the "ten-day battle", planning to screen more than 10 million community populations for COVID-19 within 10 days. On May 13th, a team of more than 30 key elites from Guangzhou, Shanghai, Zhengzhou, Hefei and other places gathered at the Hybribio Wuhan Medical Laboratory to invest in the enhanced secondary biosafety experiment that has been deployed for the restart of Wuhan. In the room, full power, day and night, contributed to the power of national enterprises to serve the motherland for the "ten-day battle" in Wuhan.

— Xinjiang·War Epidemic —

On July 24th, Hybribio Biosciences aided Xinjiang's anti-epidemic technical team assembled at Urumqi Airport. They represented Hybribiotain's experienced specialists in Guangzhou, Shanghai, Nanjing, Zhengzhou, Xi'an, Heilongjiang and other places, and fully supported Xinjiang's novel coronavirus nucleic acid detection work. With such a mission. every technical expert member of the Xinjiang-aid anti-epidemic combat team has gone through the "war epidemic" test, has rich anti-epidemic experience, and proficient professional technology. It can help the local area to quickly improve the Japanese nucleic acid detection capabilities and strive to improve the local Japanese nucleic acid detection capabilities, which is about 1,000 servings at the beginning and currently 10,000 servings.

— Dalian War Epidemic —

Hybribio Shenyang Medical Laboratory, as a third-party institution that can carry out nucleic acid testing for COVID-19 in Liaoning Province, quickly entered the war against the epidemic and quickly undertook the nucleic acid testing task assigned by the Dalian Municipal Health Commission. So far, nearly 500,000 nucleic acid tests for the novel coronavirus have been completed, and the screening results are exactly the same as those of the Liaoning Provincial Center for Disease Control and Prevention. We will try our best to maintain and guarantee the hard-won production and life order.